Related references
Note: Only part of the references are listed.Curcumin-Targeting Pericellular Serine Protease Matriptase Role in Suppression of Prostate Cancer Cell Invasion, Tumor Growth, and Metastasis
Tai-Shan Cheng et al.
CANCER PREVENTION RESEARCH (2013)
Persistent elevation of hepatocyte growth factor activator inhibitors in cholangiopathies affects liver fibrosis and differentiation
Hsiang-Po Huang et al.
HEPATOLOGY (2012)
Increased matriptase zymogen activation in inflammatory skin disorders
Cheng-Jueng Chen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2011)
c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase
R. Szabo et al.
ONCOGENE (2011)
Matriptase Is Involved in ErbB-2-Induced Prostate Cancer Cell Invasion
Shang Ru Wu et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment
Toni M. Antalis et al.
BIOCHEMICAL JOURNAL (2010)
Loss of the Matriptase Inhibitor HAI-2 During Prostate Cancer Progression
Christopher Bergum et al.
PROSTATE (2010)
Mutations in SPINT2 Cause a Syndromic Form of Congenital Sodium Diarrhea
Peter Heinz-Erian et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
Herbal Extract of Wedelia chinensis Attenuates Androgen Receptor Activity and Orthotopic Growth of Prostate Cancer in Nude Mice
Chin-Hsien Tsai et al.
CLINICAL CANCER RESEARCH (2009)
Regulation of cell surface protease matriptase by HAI2 is essential for placental development, neural tube closure and embryonic survival in mice
Roman Szabo et al.
DEVELOPMENT (2009)
An Epigenetic Genome-Wide Screen Identifies SPINT2 as a Novel Tumor Suppressor Gene in Pediatric Medulloblastoma
Paul N. Kongkham et al.
CANCER RESEARCH (2008)
Zymogen activation, inhibition, and ectodomain shedding of matriptase
Chen-Yong Lin et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Potent Inhibition and Global Co-localization Implicate the Transmembrane Kunitz-type Serine Protease Inhibitor Hepatocyte Growth Factor Activator Inhibitor-2 in the Regulation of Epithelial Matriptase Activity
Roman Szabo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Autoactivation of matriptase in vitro: requirement for biomembrane and LDL receptor domain
Ming-Shyue Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
Matriptase inhibition by hepatocyte growth factor activator inhibitor-1 is essential for placental development
R. Szabo et al.
ONCOGENE (2007)
Matriptase and its putative role in cancer
K. Uhland
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Matriptase activates stromelysin (MMP-3) and promotes tumor growth and angiogenesis
Xinlian Jin et al.
CANCER SCIENCE (2006)
Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells
Christian Parr et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
A novel biomarker for staging human prostate adenocarcinoma: Overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1
M Saleem et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Matriptase: Potent proteolysis on the cell surface
Karin List et al.
MOLECULAR MEDICINE (2006)
Serum hepatocyte growth factor activator (HGFA) in benign prostatic hyperplasia and prostate cancer
O Nagakawa et al.
EUROPEAN UROLOGY (2005)
Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation
K List et al.
GENES & DEVELOPMENT (2005)
Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma
MR Morris et al.
CANCER RESEARCH (2005)
Simultaneous activation and hepatocyte growth factor activator inhibitor 1-mediated inhibition of matriptase induced at activation foci in human mammary epithelial cells
MS Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2
D Kirchhofer et al.
FEBS LETTERS (2005)
The hepatocyte growth factor regulatory factors in human breast cancer
C Parr et al.
CLINICAL CANCER RESEARCH (2004)
Characterization of matriptase expression in normal human tissues
MD Oberst et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2003)
The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor
MD Oberst et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Membrane anchored serine proteases: A rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer
S Netzel-Arnett et al.
CANCER AND METASTASIS REVIEWS (2003)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
A role for membrane-type serine protease (MT-SP1) in intestinal epithelial turnover
S Satomi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
The microenvironment of the tumour-host interface
LA Liotta et al.
NATURE (2001)
Matriptase and HAI-1 are expressed by normal and malignant epithelial cells in vitro and in vivo
M Oberst et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Observations on the antiquity of cancer and metastasis
L Weiss
CANCER AND METASTASIS REVIEWS (2000)
Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease
SL Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates
T Takeuchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
